152 related articles for article (PubMed ID: 34324707)
1. Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
Yu KJ; Hsu WL; Chiang CJ; Chen TC; Liu Z; Lou PJ; Diehl S; Goldstein AM; Chen CJ; Wang CP; Hildesheim A
Cancer; 2021 Nov; 127(22):4171-4176. PubMed ID: 34324707
[TBL] [Abstract][Full Text] [Related]
2. Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan.
Yu KJ; Hsu WL; Chiang CJ; Cheng YJ; Pfeiffer RM; Diehl SR; Goldstein AM; Gravitt PE; Chen CJ; Hildesheim A
Int J Cancer; 2009 Apr; 124(7):1622-5. PubMed ID: 19065653
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.
Lee MH; Huang YH; Coghill AE; Liu Z; Yu KJ; Hsu WL; Chien YC; Wang CP; Chen TC; Chen CJ; Hildesheim A
J Infect Dis; 2021 Feb; 223(3):441-444. PubMed ID: 32614957
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review.
Chow JCH; Lee AWM; Wong CHL; Ng WT; Liu Z; Tay JK; Loh KS; Pace-Asciak P; Cohen O; Corry J; Rodrigo JP; Tsang RKY; Lopez F; Saba NF; de Bree R; Ferlito A
Oral Oncol; 2022 Oct; 133():106031. PubMed ID: 35908365
[TBL] [Abstract][Full Text] [Related]
5. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.
Hsu WL; Chien YC; Huang YT; Yu KJ; Ko JY; Lin CY; Tsou YA; Leu YS; Liao LJ; Chang YL; Su JY; Liu Z; Wang CP; Terng SD; Hua CH; Lee JC; Yang TL; Kate Hsiao CH; Wu MS; Tsai MH; Liu MJ; Lou PJ; Hildesheim A; Chen CJ;
Cancer Med; 2020 Mar; 9(5):1867-1876. PubMed ID: 31925935
[TBL] [Abstract][Full Text] [Related]
7. Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
Chen WJ; Xu WN; Wang HY; Chen XX; Li XQ; Xie SH; Lin DF; Cao SM
BMC Cancer; 2021 Jun; 21(1):651. PubMed ID: 34074258
[TBL] [Abstract][Full Text] [Related]
8. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
9. Genomic landscape of Epstein-Barr virus in familial nasopharyngeal carcinoma.
Zhang WL; Zhang JB; Wang TM; Wu YX; He YQ; Xue WQ; Liao Y; Deng CM; Li DH; Wu ZY; Yang DW; Zheng XH; Li XZ; Zhou T; Zhang PF; Zhang SD; Hu YZ; Jia WH
J Gen Virol; 2022 Mar; 103(3):. PubMed ID: 35349400
[TBL] [Abstract][Full Text] [Related]
10. Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus.
Wang CC; Chen ML; Hsu KH; Lee SP; Chen TC; Chang YS; Tsang NM; Hong JH
Int J Cancer; 2000 Jul; 87(2):228-31. PubMed ID: 10861479
[TBL] [Abstract][Full Text] [Related]
11. Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.
Baizig NM; Morand P; Seigneurin JM; Boussen H; Fourati A; Gritli S; Oueslati Z; Touati S; Gamoudi A; Ben Abdallah M; El May M; El May A
Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1005-11. PubMed ID: 21805179
[TBL] [Abstract][Full Text] [Related]
12. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
[TBL] [Abstract][Full Text] [Related]
13. Association between solid fuel use and seropositivity against Epstein-Barr virus in a high-risk area for nasopharyngeal carcinoma.
Li M; Chen WJ; Yang J; Charvat H; Xie SH; Li T; Ling W; Lu YQ; Liu Q; Hong MH; Cao SM
Environ Pollut; 2022 Jul; 304():119184. PubMed ID: 35341821
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
Fung SY; Lam JW; Chan KC
Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
[TBL] [Abstract][Full Text] [Related]
16. Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein-Barr Virus: An analysis of a prospective study in southern China.
Hu T; Lin CY; Xie SH; Chen GH; Lu YQ; Ling W; Huang QH; Liu Q; Cao SM
Cancer Med; 2019 May; 8(5):2561-2571. PubMed ID: 30843658
[TBL] [Abstract][Full Text] [Related]
17. Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk.
Hsu WL; Yu KJ; Chien YC; Chiang CJ; Cheng YJ; Chen JY; Liu MY; Chou SP; You SL; Hsu MM; Lou PJ; Wang CP; Hong JH; Leu YS; Tsai MH; Su MC; Tsai ST; Chao WY; Ger LP; Chen PR; Yang CS; Hildesheim A; Diehl SR; Chen CJ
Am J Epidemiol; 2011 Feb; 173(3):292-9. PubMed ID: 21148719
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan.
Coghill AE; Hsu WL; Pfeiffer RM; Juwana H; Yu KJ; Lou PJ; Wang CP; Chen JY; Chen CJ; Middeldorp JM; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1213-9. PubMed ID: 24769890
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan.
Pickard A; Chen CJ; Diehl SR; Liu MY; Cheng YJ; Hsu WL; Sun B; Hsu MM; Chen IH; Chen JY; Yang CS; Mittl BL; Chou SP; Ruggles DD; Goldstein AM; Hildesheim A
Int J Cancer; 2004 Aug; 111(1):117-23. PubMed ID: 15185352
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.
Coghill AE; Pfeiffer RM; Proietti C; Hsu WL; Chien YC; Lekieffre L; Krause L; Teng A; Pablo J; Yu KJ; Lou PJ; Wang CP; Liu Z; Chen CJ; Middeldorp J; Mulvenna J; Bethony J; Hildesheim A; Doolan DL
Clin Cancer Res; 2018 Mar; 24(6):1305-1314. PubMed ID: 29301829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
